购物车
- 全部删除
- 您的购物车当前为空
hMAO-B/MB-COMT-IN-1 是 MAO-B/MB-COMT 的双重抑制剂,对 hMAO-B 的IC50值为 2.5 μM,对MB-COMT 的IC50值为 3.84 μM。hMAO-B/MB-COMT-IN-1 能保护细胞免受氧化损伤,可用于神经退行性疾病,如帕金森病 (PD)等的研究。
hMAO-B/MB-COMT-IN-1 是 MAO-B/MB-COMT 的双重抑制剂,对 hMAO-B 的IC50值为 2.5 μM,对MB-COMT 的IC50值为 3.84 μM。hMAO-B/MB-COMT-IN-1 能保护细胞免受氧化损伤,可用于神经退行性疾病,如帕金森病 (PD)等的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 10-14周 | |
50 mg | ¥ 13,800 | 10-14周 | |
100 mg | ¥ 17,500 | 10-14周 |
产品描述 | hMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor with IC50s of 2.5 μΜ for hMAO-B and 3.84 μΜ for MB-COMT. hMAO-B/MB-COMT-IN-1 protects cells from oxidative damage that can be used in neurodegeneration disease research, for example, Parkinson’s Disease (PD) [1]. |
体外活性 | hMAO-B/MB-COMT-IN-1 (compound 3, 50 μM, 24 h) decreases in resazurin reduction in differentiated SH-SY5Y cells [1]. hMAO-B/MB-COMT-IN-1 (50 μM, 24 h) displays lysosomal toxicity by producing ROS in differentiated SH-SY5Y cells [1]. hMAO-B/MB-COMT-IN-1 (10 μM, 30 min) displays remarkable cytoprotective effects against t-BHP in differentiated SH-SY5Y cells [1]. hMAO-B/MB-COMT-IN-1 is predicted to cross the blood-brain barrier (BBB) by passive diffusion, determined by the parallel artificial membrane permeability assay (PAMPA)-BBB kit [1]. |
分子量 | 273.33 |
分子式 | C16H19NO3 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容